Concomitant loss of dynorphin, NARP, and orexin in narcolepsy
Concomitant loss of dynorphin, NARP, and orexin in narcolepsy
复制标题
DOI:
10.1212/01.wnl.0000168173.71940.ab
复制
发表时间:
2005-10-25
期刊:
影响因子:
9.9
通讯作者:
Scammell, TE
中科院分区:
文献类型:
--
作者:
Crocker, A;España, RA;Scammell, TE
Background: Narcolepsy with cataplexy is associated with a loss of orexin/hypocretin. It is speculated that an autoimmune process kills the orexin-producing neurons, but these cells may survive yet fail to produce orexin. Objective: To examine whether other markers of the orexin neurons are lost in narcolepsy with cataplexy. Methods: We used immunohistochemistry and in situ hybridization to examine the expression of orexin, neuronal activity-regulated pentraxin (NARP), and prodynorphin in hypothalami from five control and two narcoleptic individuals. Results: In the control hypothalami, at least 80% of the orexin-producing neurons also contained prodynorphin mRNA and NARP. In the patients with narcolepsy, the number of cells producing these markers was reduced to about 5 to 10% of normal. Conclusions: Narcolepsy with cataplexy is likely caused by a loss of the orexin-producing neurons. In addition, loss of dynorphin and neuronal activity-regulated pentraxin may contribute to the symptoms of narcolepsy.